JOHN HALL: Open Payments
NPI 1215961180 · REIDSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,834 in 163 payments from 25 companies in 2025. Trend: 2023 $3,460 · 2024 $3,200 · 2025 $2,834
Food & beverage: $2,834
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $491 |
| Novo Nordisk Inc | 21 | $436 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $258 |
| PFIZER INC. | 16 | $206 |
| Otsuka America Pharmaceutical, Inc. | 6 | $161 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $157 |
| Kowa Pharmaceuticals America, Inc. | 28 | $157 |
| Viatris Specialty LLC | 5 | $140 |
| Exact Sciences Corporation | 4 | $78 |
Products named: VRAYLAR, Kerendia, Wegovy, REXULTI, Ozempic, CAPLYTA, ZORYVE, YUPELRI.
Industry payments across NC — which companies pay providers there.
